Joseph Tung
CIK: 0002060609
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Tung Joseph
Tung Joseph (SEC CIK 0002060609) files insider reports with the SEC as Director of Shuttle Pharmaceuticals Holdings, Inc. (SHPH) and Director of iCoreConnect Inc. (ICCT).
Signal8 holds 3 ownership filings by Tung Joseph (2 Form 3, 1 Form 4), filed between Mar 21, 2025 and Aug 12, 2025. Those filings report 1 transaction, the latest on Aug 8, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Tung Joseph's filings is in GAITHERSBURG, MD.
Recent filings by Tung Joseph
- Aug 8, 2025: Grant or award of SHPH derivative securities (Form 4, code A).
Other insiders filing for Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
- HRT FINANCIAL LP, 10% Owner
- Trasolini Ryan, Co-Chief Executive Officer
- Liang Yuying, Chief Financial Officer
- Liriano Angel, Director
- Pathigoda Arachchige Sachin Eranga, Director
- Chambers Adam V, Director